Olfactory Groove Meningioma

Otolaryngologic Clinics of North America

Volumn 44, Issue 4, 2011, Pages 965-980

  Adappa, Nithin D ^a   Lee, John Y K ^a   Chiu, Alexander G ^b   Palmer, James N ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Endoscopic; Paranasal; Sinus; Skull Base; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; HYDROXYUREA; IMATINIB; MIFEPRISTONE; PROTEINASE INHIBITOR; SORAFENIB; SUNITINIB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; ENDOSCOPIC SURGERY; ENDOSCOPY; EPILEPSY; EXOPHTHALMOS; FOLLOW UP; FOSTER KENNEDY SYNDROME; HEAD INJURY; HEADACHE; HUMAN; INCONTINENCE; MENINGIOMA; MOLECULARLY TARGETED THERAPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY GROOVE MENINGIOMA; OPTIC NERVE ATROPHY; PAPILLEDEMA; PHYSICAL EXAMINATION; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; SINUSITIS; STEREOTACTIC RADIOSURGERY; TELECANTHUS; TUMOR RECURRENCE; VISUAL IMPAIRMENT;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; ENDOSCOPY; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MOLECULAR TARGETED THERAPY; PATIENT SELECTION; RADIATION, IONIZING; RADIOSURGERY; RADIOTHERAPY; RECURRENCE; RISK FACTORS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79960989851     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2011.06.001     Document Type: Review

References (63)

1. Derome P.J., Guiot G. Bone problems in meningiomas invading the base of the skull. Clin Neurosurg 1978, 25:435-451.
2. McDermott M.W., Wilson C.B. Meningiomas 1996, Saunders, Philadelphia. 4th edition.
3. Hallacq P., Moreau J.J., Fischer G., et al. Trans-sinusal frontal approach for olfactory groove meningiomas. Skull Base 2001, 11(1):35-46.
4. Cushing H., Eisenhardt L. The olfactory groove meningiomas with primary anosmia. Meningiomas: their classification, regional behavior, life history and surgical end results 1938, 250-273. Charles C Thomas, Springfield (MA).
5. Goyal L.K., Suh J.H., Mohan D.S., et al. Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 2000, 46(1):57-61.
6. Hentschel S.J., DeMonte F. Olfactory groove meningiomas. Neurosurg Focus 2003, 14(6):e4.
7. Rowland L.P., Pedley T.A. Merritt's neurology 2009, Lippincott Williams & Wilkins, Philadelphia.
8. Norden A.D., Drappatx J., Wen P.Y. Advances in meningioma therapy. Curr Neurol Neurosci Rep 2009, 9(3):231-240.
9. Louis D.N., Budka H., von Deimling A., et al. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system 2000, 176-184. IARC Press, Lyon (France). P. Kielhues, W.K. Cavenee (Eds.).
10. Lee J.Y., Finkelstein S., Hamilton R.L., et al. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery 2004, 55(5):1163-1173.
11. Shen Y., Nunes F., Stemmer-Rachamimov A., et al. Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas. BMC Med Genomics 2009, 2:42.
12. Hansson C.M., Buckley P.G., Grigelioniene G., et al. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. BMC Genomics 2007, 8:16.
13. Ragel B.T., Jensen R.L. Molecular genetics of meningiomas. Neurosurg Focus 2005, 19(5):E9.
14. Lee Y., Liu J., Patel S., et al. Genomic landscape of meningiomas. Brain Pathol 2010, 20(4):751-762.
15. Riemenschneider M.J., Perry A., Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol 2006, 5(12):1045-1054.
16. Hijiya N., Hudson M.M., Lensing S., et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 2007, 297(11):1207-1215.
17. Preston D.L., Ron E., Yonehara S., et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 2002, 94(20):1555-1563.
18. Ron E., Modan B., Bolce J.D., et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988, 319(16):1033-1039.
19. Sadetzki S., Flint-Richter P., Starinsky S., et al. Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev 2005, 14(4):969-976.
20. Sadetzki S., Flint-Richeter P., Ben-Tai T., et al. Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg 2002, 97(5):1078-1082.
21. Wiemels J., Wrensch M., Claus E.B. Epidemiology and etiology of meningioma. J Neurooncol 2010, 99(3):307-314.
22. Claus E.B., Black P.M., Bondy M.L., et al. Exogenous hormone use and meningioma risk: what do we tell our patients?. Cancer 2007, 110(3):471-476.
23. Vadivelu S., Sharer L., Schulder M. Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. J Neurosurg 2010, 112(5):920-924.
24. Phillips L.E., Koepseil T.D., Van Belle G., et al. History of head trauma and risk of intracranial meningioma: population-based case-control study. Neurology 2002, 58(12):1849-1852.
25. Preston-Martin S., Paganini-Hill A., Henderson B.E., et al. Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst 1980, 65(1):67-73.
26. Annegers J.F., Laws E.R., Kurland L.T., et al. Head trauma and subsequent brain tumors. Neurosurgery 1979, 4(3):203-206.
27. Eskandary H., Sabba M., Khajehpur F., et al. Incidental findings in brain computed tomography scans of 3000 head trauma patients. Surg Neurol 2005, 63(6):550-553. [discussion: 553].
28. Brenner A.V., Linet M.S., Fine H.A., et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002, 99(2):252-259.
29. Krampla W., Newrkia S., Pfisterer W., et al. Frequency and risk factors for meningioma in clinically healthy 75-year-old patients: results of the Transdanube Ageing Study (VITA). Cancer 2004, 100(6):1208-1212.
30. Vernooij M.W., Ikram M.A., Tanghe H.L., et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007, 357(18):1821-1828.
31. Bakay L., Cares H.L. Olfactory meningiomas. Report on a series of twenty-five cases. Acta Neurochir (Wien) 1972, 26(1):1-12.
32. Tsikoudas A., Martin-Hirsch D.P. Olfactory groove meningiomas. Clin Otolaryngol Allied Sci 1999, 24(6):507-509.
33. DeMonte F. Surgical treatment of anterior basal meningiomas. J Neurooncol 1996, 29(3):239-248.
34. Spektor S., Valarezo J., Fliss D.M., et al. Olfactory groove meningiomas from neurosurgical and ear, nose, and throat perspectives: approaches, techniques, and outcomes. Neurosurgery 2005, 57(Suppl 4):268-280. [discussion: 268-80].
35. Turazzi S., Cristofori L., Gambin R., et al. The pterional approach for the microsurgical removal of olfactory groove meningiomas. Neurosurgery 1999, 45(4):821-825. [discussion: 825-6].
36. Hassler W., Zentner J. Pterional approach for surgical treatment of olfactory groove meningiomas. Neurosurgery 1989, 25(6):942-945. [discussion 945-7].
37. Obeid F., Al-Mefty O. Recurrence of olfactory groove meningiomas. Neurosurgery 2003, 53(3):534-542. [discussion: 542-3].
38. Gardner P.A., Kassam A.B., Thomas A., et al. Endoscopic endonasal resection of anterior cranial base meningiomas. Neurosurgery 2008, 63(1):36-52. [discussion: 52-4].
39. Hadad G., Bassagastegy L., Carrau R.L., et al. A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope 2006, 116(10):1882-1886.
40. Chhabra N., Houser S.M. The diagnosis and management of empty nose syndrome. Otolaryngol Clin North Am 2009, 42(2):311-330. ix.
41. Lee J.Y., Niranjan A., McInerney J., et al. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 2002, 97(1):65-72.
42. Harris A.E., Lee J.Y., Omalu B., et al. The effect of radiosurgery during management of aggressive meningiomas. Surg Neurol 2003, 60(4):298-305. [discussion: 305].
43. Torres R.C., Frighetto L., De Salles A.A., et al. Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. Neurosurg Focus 2003, 14(5):e5.
44. Kubo O., Chernov M., Izawa M., et al. Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation?. Minim Invasive Neurosurg 2005, 48(6):334-339.
45. Chamberlain M.C., Tsao-Wei D.D., Groshen S. Temozolomide for treatment-resistant recurrent meningioma. Neurology 2004, 62(7):1210-1212.
46. Chamberlain M.C., Tsao-Wei D.D., Groshen S. Salvage chemotherapy with CPT-11 for recurrent meningioma. J Neurooncol 2006, 78(3):271-276.
47. Newton H.B. Hydroxyurea chemotherapy in the treatment of meningiomas. Neurosurg Focus 2007, 23(4):E11.
48. Chamberlain M.C., Glantz M.J., Fadul C.E. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 2007, 69(10):969-973.
49. Simon M., Bostrom J.P., Hartmann C. Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery 2007, 60(5):787-798. [discussion: 787-98].
50. Wen P.Y., Drappatz J. Novel therapies for meningiomas. Expert Rev Neurother 2006, 6(10):1447-1464.
51. Gupta V., Samuleson C.G., Su S., et al. Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition. Neurosurg Focus 2007, 23(4):E9.
52. Kerbel R.S. Tumor angiogenesis. N Engl J Med 2008, 358(19):2039-2049.
53. Lamszus K., Lengler U., Schmidt N.O., et al. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 2000, 46(4):938-947. [discussion: 947-8].
54. Kan P., Liu J.K., Wendland M.M., et al. Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. J Neurooncol 2007, 83(1):33-38.
55. Provias J., Claffey K., Del Aguila L., et al. Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 1997, 40(5):1016-1026.
56. Goodwin J.W., Crowley J., Eyre H.J., et al. A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study. J Neurooncol 1993, 15(1):75-77.
57. Grunberg S.M., Rankin C., Townsend J., et al. Phase III double-blind randomized placebo-controlled study of mifepristone (RU) for the treatment of unresectable meningioma. Proc ASCO 2001, 20:222. [abstract].
58. Solero C.L., Giombini S., Morello G. Suprasellar and olfactory meningiomas. Report on a series of 153 personal cases. Acta Neurochir (Wien) 1983, 67(3-4):181-194.
59. Tuna H., Bozkurt M., Ayten M., et al. Olfactory groove meningiomas. J Clin Neurosci 2005, 12(6):664-668.
60. Lamszus K. Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 2004, 63:275-286.
61. Black P.M., Morokoff A.P., Zauberman J. Surgery for extra-axial tumors of the cerebral convexity and midline. Neurosurgery 2008, 62:1115-1121. [discussion: 1121-3].
62. Jaaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986, 26:461-469.
63. Yang S.Y., Park C.K., Park S.H., et al. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 2008, 79:574-580.